Comment on “Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group
Journal article published in 2023 by
Ray S. Lin,
Pralay Mukhopadhyay,
Satrajit Roychoudhury 
,
Keaven M. Anderson,
Tianle Hu,
Bo Huang,
Larry F. Leon,
Jason J. Z. Liao,
Ji Lin,
Rong Liu,
Xiaodong Luo,
Yabing Mai,
Rui Qin,
Kay Tatsuoka,
Yang Wang
and other authors.
,
Keaven M. Anderson,
Tianle Hu,
Bo Huang,
Larry F. Leon,
Jason J. Z. Liao,
Ji Lin,
Rong Liu,
Xiaodong Luo,
Yabing Mai,
Rui Qin,
Kay Tatsuoka,
Yang Wang
and other authors.
